ALBO

Odevixibat (A4250)

Progressive familial intrahepatic cholestasis (PFIC)

Stage (next event)

Expected Date

Regulatory Filings

H1 2020

Catalyst Info & Data Links

TITLE: Odevixibat for Progressive familial intrahepatic cholestasis (PFIC)  Regulatory Filings 

  • Clinical Trial (NCT03659916): Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC


WHAT IS THE NEXT CATALYST EVENT?

  • Regulatory Filings 


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • H1 2021


PRIOR DATA/EVENTS

PRESS RELEASES

MECHANISM OF ACTION 

Updated by MV

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See what the community is saying - click to see full post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon